Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients
Authors
Keywords
Sarcopenia, Obesity, Nivolumab, Pembrolizumab, Melanoma, Toxicity
Journal
INVESTIGATIONAL NEW DRUGS
Volume 35, Issue 4, Pages 436-441
Publisher
Springer Nature
Online
2017-04-10
DOI
10.1007/s10637-017-0464-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer
- (2016) Bjørg Sjøblom et al. CLINICAL NUTRITION
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer
- (2016) Amanika Kumar et al. GYNECOLOGIC ONCOLOGY
- Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
- (2016) Se-Il Go et al. Journal of Cachexia Sarcopenia and Muscle
- Lean body mass as an independent determinant of dose-limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens
- (2016) Raafi Ali et al. Cancer Medicine
- Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer
- (2015) B.H.L. Tan et al. EJSO
- Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
- (2015) Antoni Ribas et al. LANCET ONCOLOGY
- Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
- (2015) Jeffrey S Weber et al. LANCET ONCOLOGY
- The cost of ipilimumab toxicity
- (2015) Nadia Yousaf et al. MELANOMA RESEARCH
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sarcopenia Is Linked to Treatment Toxicity in Patients With Metastatic Colorectal Cancer
- (2014) Maximilien Barret et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy
- (2014) Hee-Won Jung et al. SUPPORTIVE CARE IN CANCER
- Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients
- (2013) O Huillard et al. BRITISH JOURNAL OF CANCER
- Body Composition Variation and Impact of Low Skeletal Muscle Mass in Patients With Advanced Medullary Thyroid Carcinoma Treated With Vandetanib: Results From a Placebo-Controlled Study
- (2013) Marie-Hélène Massicotte et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
- (2013) Lisa Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma
- (2012) Olivier Mir et al. PLoS One
- Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma
- (2011) Michael S. Sabel et al. ANNALS OF SURGICAL ONCOLOGY
- Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma
- (2010) S. Antoun et al. ANNALS OF ONCOLOGY
- A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care
- (2008) Marina Mourtzakis et al. Applied Physiology Nutrition and Metabolism
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
- (2008) Carla MM Prado et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search